22.07.2019 • NewsElaine BurridgeEvonikPerstorp

Evonik and Perstorp Link on Animal Health

Evonik and Perstorp Link on Animal Health
Evonik and Perstorp Link on Animal Health

Evonik has signed an agreement with Swedish specialty chemicals company Perstorp to research and develop new animal nutrition products along with investigating future options for commercial partnerships.

The focus of the collaboration is improving gut health. Evonik will provide access to its gut health simulation system and probiotics portfolio while Perstorp will supply its ester technology platform. The companies said the partnership will combine advanced science and practical experience to deliver “breakthrough innovation” to support the needs of tomorrow’s animal farming.

“Both companies believe that the challenges of antimicrobial resistance in animal production can only be tackled with a holistic approach, using new and innovative solutions instead of the preventive use of antibiotics,” said Christoph Kobler, head of Evonik’s sustainable healthy nutrition product lines. “This approach will help to ensure that sustainable livestock production remains possible without resorting to that intervention.”

Last month, Evonik signed another animal health deal, that time with Chinese biotech Vland. The companies signed a joint development agreement (JDA) as part of an existing broader partnership in probiotics for animal nutrition and enzymes for industrial applications.

“The JDA is expected to stimulate innovation and joint R&D activities in the field of selection, production, formulation and application of our new probiotic solution,” said Emmanuel Auer, head of Evonik’s animal nutrition business.

Vland’s CEO Aron Chen added that based on years of cooperation, the companies had extended the scope of their alliance to plant, livestock and aquaculture.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.